The feasibility of extracorporeal cardiopulmonary resuscitation for patients with active cancer who undergo in-hospital cardiac arrest

Shin, Yo Sep; Kang, Pil Je; Kim, Youn-Jung; Ryoo, Seung Mok; Jung, Sung-Ho; Hong, Sang-Bum; Kim, Won Young

doi:10.1038/s41598-022-05786-8

Cited by 5 publications

(3 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 62 , 63 Extracorporeal cardiopulmonary resuscitation indications in cancer patients are unclear, but understanding IHCA outcomes in this population is essential due to the incidence of cancer and improved survival rates. 64 Veno-arterial ECMO is a suitable treatment option for poisoning cases complicated by refractory cardiogenic shock or cardiac arrest, offering high survival rates with low complications. 65 Extracorporeal membrane oxygenation may be indicated in severe status asthmaticus, 66 pheochromocytoma-induced cardiomyopathy, 67 , 68 fulminant myocarditis, 69 ANCA-associated vasculitis, 70 and refractory thyroid storm.…”

Section: Indicationsmentioning

confidence: 99%

Is Extracorporeal Membrane Oxygenation a Panacea?

Karaoğlanoğlu,

Akgün

2024

The Eurasian Journal of Medicine

View full text Add to dashboard Cite

Extracorporeal membrane oxygenation (ECMO) has emerged as a vital life-support technique in critical care medicine, providing temporary circulatory and/or respiratory support for patients with severe cardiac or respiratory failure unresponsive to conventional therapies. This review aims to outline the importance of ECMO and provide a comprehensive overview of its main applications. Two primary types of ECMO, veno-arterial extracorporeal membrane oxygenation and veno-venous extracorporeal membrane oxygenation, serve distinct functions in supporting patients with cardiac or pulmonary dysfunction, respectively. While ECMO offers life-saving potential, its utilization requires careful consideration due to its cost and resource-intensiveness. Thus, a comprehensive evaluation of an individual patient’s clinical condition, prognosis, and potential for recovery is crucial. Ongoing research and technological advancements continually refine ECMO techniques, enhance patient selection criteria, and improve long-term outcomes. Within this narrative review, we present an updated approach to patient selection and ECMO utilization, supported by a detailed literature review. By consolidating the current evidence, we aim to provide healthcare professionals with valuable insights into the ECMO’s post-pandemic role.

show abstract

Section: Indicationsmentioning

confidence: 99%

Is Extracorporeal Membrane Oxygenation a Panacea?

Karaoğlanoğlu,

Akgün

2024

The Eurasian Journal of Medicine

View full text Add to dashboard Cite

show abstract

“…A growing body of evidence supports the use of ECMO in patients with refractory cardiac arrest during CPR or ECPR [16][17][18]. In one meta-analysis [19] [21]. Recently, Tonna et al [22] developed a model for predicting mortality in in-hospital cardiac arrest patients receiving ECPR which showed good discrimination.…”

Section: Indication For Ecmo: Ecprmentioning

confidence: 99%

Clinical characteristics and outcomes of extracorporeal membrane oxygenation used in a non-cardiac surgical intensive care unit: Siriraj experiences and literature review

2023

View full text Add to dashboard Cite

Background: Extracorporeal membrane oxygenation (ECMO) has substantially increased in frequency of use over the past decades. Occasionally, patients who require ECMO support are admitted to an ICU rather than medical or cardiac ICU, where physicians may be not familiar with the process of how to care for ECMO patients. The aims of this case series were to explore the utilization of ECMO support in a non-cardiac general surgical ICU (SICU) in terms of indications, ECMO-related complications and clinical outcomes. Methods: Adult patients admitted to the SICU from January 2014 to June 2021 who received ECMO support were included. Demographic data, data regarding ECMO utilization and clinical outcomes were described. Current evidence and updated literature were also researched and reviewed. Results: A total of 18 patients were admitted to the SICU and received ECMO support, but four died within four hours of SICU admission. The most common reason for ECMO support was extracorporeal cardiopulmonary resuscitation (ECPR) (9 cases, 50.0%), followed by cardiac and/or respiratory support. The majority of patients received venoarterial ECMO support (15 cases, 83.3%). Unfractionated heparin was used in 10 cases (71.4%) and the anticoagulant effect was monitored with aPTT, which was maintained at a lower range (30–50 seconds). There was no thromboembolic event, and four patients (28.6%) developed major bleeding. The overall hospital mortality was as high as 77.8%. Conclusion: There was a small volume of cases receiving ECMO support in the SICU. ECPR was the most common reason for ECMO support in these patients. Overall, the hospital mortality was 77.8%. To improve outcomes in these patients, appropriate patient selection, well-organized protocols, and a multidisciplinary approach are mandatory.

show abstract

“… 1 , 2 There have been over 350,000 out-of-hospital cardiac arrests and 475,000 cardiac arrests resulting in death annually. 3 Extracorporeal cardiopulmonary resuscitation (ECPR) is a rescue intervention for refractory cardiac arrest patients, 4 , 5 employing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) to restore continuous circulation. 6 The lack of perfusion from refractory cardiac arrest leads to neurological dysfunction.…”

Section: Introductionmentioning

confidence: 99%